|
WO2007068053A1
|
|
Recombinant protein production
|
|
CN101090732A
|
|
Method for treating diabetes
|
|
CA2565886A1
|
|
Treatment of inflammatory airway disease
|
|
AUPS282002A0
|
|
Metalloproteinase inhibitors
|
|
AUPS241602A0
|
|
Treatment of damaged nasal and sinus epithelial tissue
|
|
AU2291102A
|
|
Compositions and methods for the treatment of skin damage
|
|
AU5452301A
|
|
Treatment of damaged connective tissue
|
|
AU3525301A
|
|
Treatment for peripheral sensory neuropathy
|
|
AU2494401A
|
|
Growth factor splice variant
|
|
AUPQ729000A0
|
|
Treatment of damaged connective tissue
|
|
AU3398999A
|
|
Matrix binding factor
|
|
AU1475199A
|
|
Bovine milk growth factor
|
|
US6319522B1
|
|
Growth-promoting agent
|
|
EP0545946A1
|
|
Growth-promoting agent
|
